HELX vs. BTEC

Last updated Apr 2, 2026

Compare and contrast key facts about Franklin Genomic Advancements ETF (HELX) and Principal Healthcare Innovators Index ETF (BTEC).

HELX and BTEC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. HELX is an actively managed fund by Franklin Templeton. It was launched on Feb 25, 2020. BTEC is a passively managed fund by Principal that tracks the performance of the NASDAQ U.S. Health Care Innovators Index. It was launched on Aug 19, 2016.

Performance

HELX vs. BTEC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Franklin Genomic Advancements ETF (HELX) and Principal Healthcare Innovators Index ETF (BTEC). The values are adjusted to include any dividend payments, if applicable.

HELX vs. BTEC - Yearly Performance Comparison

	2026 (YTD)
HELX Franklin Genomic Advancements ETF	-4.82%
BTEC Principal Healthcare Innovators Index ETF	0.00%

Returns By Period

HELX

• 1D: 0.90%
• 1M: -2.17%
• YTD: -8.14%
• 6M: 5.21%
• 1Y: 26.31%
• 3Y*: 3.29%
• 5Y*: -5.21%
• 10Y*: —

BTEC

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HELX vs. BTEC - Expense Ratio Comparison

HELX has a 0.50% expense ratio, which is higher than BTEC's 0.42% expense ratio.

HELX

Franklin Genomic Advancements ETF

BTEC

Principal Healthcare Innovators Index ETF

Return for Risk

HELX vs. BTEC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HELX

HELX Risk / Return Rank: 53
HELX Sharpe Ratio Rank: 60
HELX Sortino Ratio Rank: 61
HELX Omega Ratio Rank: 53
HELX Calmar Ratio Rank: 47
HELX Martin Ratio Rank: 43

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HELX vs. BTEC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and Principal Healthcare Innovators Index ETF (BTEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HELX	BTEC	Difference
Sharpe ratio Return per unit of total volatility	1.10	—	—
Sortino ratio Return per unit of downside risk	1.63	—	—
Omega ratio Gain probability vs. loss probability	1.21	—	—
Calmar ratio Return relative to maximum drawdown	1.33	—	—
Martin ratio Return relative to average drawdown	4.32	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	HELX	BTEC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.10	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.22	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.21	—	—

Dividends

HELX vs. BTEC - Dividend Comparison

HELX's dividend yield for the trailing twelve months is around 0.43%, while BTEC has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020
HELX Franklin Genomic Advancements ETF	0.43%	0.39%	0.00%	0.00%	0.00%	0.24%	0.12%
BTEC Principal Healthcare Innovators Index ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

HELX vs. BTEC - Drawdown Comparison

The maximum HELX drawdown since its inception was -58.75%, which is greater than BTEC's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for HELX and BTEC.

Drawdown Indicators

	HELX	BTEC	Difference
Max Drawdown Largest peak-to-trough decline	-58.75%	0.00%	-58.75%
Max Drawdown (1Y) Largest decline over 1 year	-18.01%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-58.75%	—	—
Current Drawdown Current decline from peak	-42.36%	0.00%	-42.36%
Average Drawdown Average peak-to-trough decline	-34.12%	0.00%	-34.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.56%	—	—

Volatility

Volatility by Period

	HELX	BTEC	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.75%	—	—
Volatility (6M) Calculated over the trailing 6-month period	15.40%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	24.21%	0.00%	+24.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.26%	0.00%	+24.26%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.46%	0.00%	+27.46%